Inflammatory Breast Cancer Guide: Symptoms, Treatment and Patient Support

The following overview is designed to help you navigate the complexities of inflammatory breast cancer (IBC). While this information is comprehensive, it should serve as a foundation for deeper discussions with your oncology team.

Overview

Inflammatory breast cancer is a rare and aggressive form of breast cancer that accounts for about 1% to 5% of all breast cancers diagnosed in the United States. Unlike more common forms of the disease, IBC often does not present as a distinct lump. Instead, cancer cells block the lymphatic vessels in the skin of the breast.

This blockage causes the breast to appear swollen, red and inflamed. Because it progresses rapidly — often within weeks or months — IBC is typically diagnosed at stage 3 or 4. Prompt medical intervention is critical for managing the disease effectively.

Diagnosis

Diagnosing IBC requires a combination of physical examination and advanced imaging. Because the symptoms often mimic mastitis (a breast infection), doctors may first prescribe antibiotics. If symptoms do not improve within a week, further testing is mandatory.

• Clinical Exam: Doctors look for the "peau d'orange" (skin of an orange) appearance, caused by fluid buildup and skin thickening.
• Imaging: Mammograms, ultrasounds and MRIs are used to identify underlying masses or skin thickening.
• Biopsy: A skin punch biopsy or a needle biopsy of a suspected mass is the only way to confirm the presence of cancer cells in the lymph channels.
• Staging: Because of its aggressive nature, doctors often order PET scans or CT scans of the chest, abdomen and bones to determine if the cancer has spread.

Treatment options

IBC is treated using a multimodal approach. This means using several types of treatment in a specific sequence to achieve the best results.

1. Neoadjuvant Chemotherapy

Treatment almost always begins with systemic chemotherapy to shrink the tumor and clear the skin involvement before surgery. This typically lasts four to six months.

2. Surgery

Once chemotherapy has reduced the inflammation, a modified radical mastectomy is performed. This involves removing the entire breast and the underlying lymph nodes. Breast-conserving surgery (lumpectomy) is generally not recommended for IBC.

3. Radiation therapy

Post-operative radiation is standard for IBC. It targets the chest wall and lymph node areas to destroy any remaining microscopic cancer cells and reduce the risk of recurrence.

4. Targeted and Hormonal Therapy

If the cancer cells express certain receptors, such as HER2 or estrogen receptors, specific drugs, like Herceptin (trastuzumab) or aromatase inhibitors, will be added to the long-term treatment plan.

Side effects

Treatment for IBC is intensive, and side effects vary depending on the therapy used.

• Chemotherapy: Common effects include fatigue, hair loss, nausea and an increased risk of infection due to low white blood cell counts.
• Surgery: Patients may experience limited range of motion in the shoulder or lymphedema, a chronic swelling of the arm caused by the removal of lymph nodes.
• Radiation: Skin irritation (similar to a severe sunburn) in the treated area is common, along with persistent fatigue.
• Targeted Therapies: These can sometimes affect heart function or cause skin rashes, requiring regular monitoring by your specialist.

Conclusion

An inflammatory breast cancer diagnosis is undeniably overwhelming due to its rapid onset and intensive treatment requirements. However, advancements in multimodal therapy have significantly improved outcomes over the last decade.

The most important step in your journey is maintaining an open, honest dialogue with your multidisciplinary team, which includes your surgeon, medical oncologist and radiation oncologist. Use this guide to ask about your specific subtype, the goals of your chemotherapy and your long-term survivorship plan.

Editor's note: This article is for informational purposes only and is not a substitute for professional medical advice, as your own experience will be unique. Use this article to guide discussions with your oncologist. Content was generated with AI, reviewed by a human editor, but not independently verified by a medical professional.

For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.